share_log

Craig-Hallum Maintains Buy on Avid Bioservices, Lowers Price Target to $16

Craig-Hallum Maintains Buy on Avid Bioservices, Lowers Price Target to $16

Craig-Hallum 維持對Avid Bioservices的買入,將目標股價下調至16美元
Benzinga ·  2023/12/08 12:11

Craig-Hallum analyst Matt Hewitt maintains Avid Bioservices (NASDAQ:CDMO) with a Buy and lowers the price target from $22 to $16.

Craig-Hallum分析師馬特·休伊特維持Avid Bioservices(納斯達克股票代碼:CDMO)的買入,並將目標股價從22美元下調至16美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論